Phathom Pharmaceuticals

Our exciting new Direct-to-Consumer (DTC) campaign is spreading the word about our recently approved treatment for Erosive GERD. The first-and-only of its kind, this treatment represents a new option for the 20M Americans with the condition. Learn more: https://lnkd.in/g68NZiAA

Members of our #Phathom leadership team will participate in the Jefferies Global Health Conference on June 5 at 12:30pm ET and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11 at 2:40pm ET. Learn more: https://bit.ly/3yBCt2B

We are proud to support the World Gastroenterology Organisation (WGO)’s #WorldDigestiveHealthDay! This year’s theme “Your Digestive Health: Make it a Priority” is centered around the importance of focusing on digestive health and empowering individuals to proactively manage their wellbeing to mitigate the risk of GI disorders. Learn more about #WDHD2024 and the pivotal role #YourDigestiveHealth plays in overall health: https://lnkd.in/d2FuMBEn

As we reflect on #DDW2024, we’d like to thank everyone who stopped by our booth and attended our presentations. It was great to share all that's happening at Phathom as we work to improve the lives of patients with GI disorders. Revisit our data at https://bit.ly/PHATpubs

In recognition of Memorial Day, we remember, honor, and celebrate those who sacrificed their lives in service to our country. Phathom’s offices will be closed Friday and Monday as we pay our respects this #MemorialDay.

We’re pleased to share that a Phathom-sponsored Phase 3 study has been published in the American Gastroenterological Association (AGA)'s official clinical practice journal, Clinical Gastroenterology and Hepatology! The study evaluates an investigational treatment for the relief of heartburn associated with Non-Erosive reflux disease, also known as Non-Erosive #GERD. Check out the full study: https://bit.ly/4bciztf

Join us to hear the first oral presentation of our investigational Phase 3 study evaluating our novel treatment for Non-Erosive GERD—and how our work may transform the future of GI treatment. We look forward to seeing you there!

We’re here in the nation’s capital at #DDW2024! Our team is ready to share more about how we’re working to transform the future of the GI treatment landscape. Stop by booth 911 from May 19-21 to speak with members of our team about all that's happening at Phathom.

We’re excited to share our latest data on acid-related gastrointestinal (GI) disease treatment with three posters and an oral presentation at #DDW2024! To learn more, click the link below or visit us at booth 911. https://bit.ly/4bo1fBB

One more cheers to pHive years! We recently came together to celebrate our pHifth anniversary and couldn’t be prouder of all that our #PhathomPhamily has accomplished during this short time. Our colleagues enjoyed a wonderful evening reflecting on the journey that brought us here and looking forward to the future milestones ahead. #HappyAnniversary